drugset / Trial / NCT00663377

Effects of Losartan on Insulin Resistance in Patients With Heart Failure

NCT00663377

Phase 4 Completed 16 enrolled Tottori University Hospital
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to evaluate the effects of losartan, an ARB, on glucose metabolism and inflammatory cytokines in CHF patients treated with ACE inhibitors.

Timeline

Start
2006-04
Primary completion
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Losartan Other / unclassified 50 mg
Subject Losartan Other / unclassified 100 mg

Indications